Zubeyde Malkan

Zubeyde Malkan

Auto-generated profile, based on publicly available information

Zubeyde Malkan

Faculty of Medicine, Department of Obstetrics and Gynecology, Firat University, Elazig, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
MOMiray Onat
Miray Onat
EKEbru Celik Kavak
Ebru Celik Kavak
CACıgdem AKCABAY
Cıgdem AKCABAY
ZMZubeyde Malkan
Zubeyde Malkan
TKTugba Kaya
Tugba Kaya
SKSalih Burcin Kavak
Salih Burcin Kavak
Preeclampsia is a complex, multisystem obstetric disorder characterized by heterogeneous clinical manifestations, often requiring enhanced strategies for early detection, management, and risk stratification. This study aimed to evaluate potential alterations in non-invasive transcutaneous bilirubin levels measured at various maternal body sites in pregnant women diagnosed with preeclampsia. A total of 86 pregnant women who delivered at our institution were enrolled and classified into three groups: healthy pregnant women (Group 1, n = 30), women with preeclampsia (Group 2, n = 30), and women with pre-eclampsia with severe features (Group 3, n = 26). In addition to routine pre-delivery laboratory assessments, transcutaneous bilirubin levels were measured at two anatomical sites—the forehead and the abdominal skin overlying the uterine fundus—using a standard bilirubinometer. Each site was measured three times, and the mean of the three readings was recorded for analysis. Complete Blood Count and biochemical blood parameters of the women were evaluated. Relevant obstetric and demographic data were also collected and recorded. There were no statistically significant differences among the three groups in terms of maternal age, gravidity, parity, or body mass index (p > 0.05). Similarly, total serum bilirubin levels were comparable across the groups (Group 1: 0.45 mg/dL; Group 2: 0.39 mg/dL; Group 3: 0.44 mg/dL; p > 0.05). In contrast, transcutaneous bilirubin levels were significantly elevated in Group 3 compared to Groups 1 and 2. The mean transcutaneous bilirubin values for the forehead, uterine fundus, and overall (combined sites) were as follows: Group 1—3.07 ± 0.85, 2.35 ± 0.97, and 2.71 ± 0.76; Group 2—6.09 ± 1.94, 4.94 ± 1.64, and 5.52 ± 1.59; Group 3—7.12 ± 1.81, 6.12 ± 2.25, and 6.63 ± 1.69, respectively. All pairwise comparisons demonstrated statistically significant differences (p < 0.05). Transcutaneous bilirubin levels were significantly elevated in women with preeclampsia, particularly among those with severe disease. As a non-invasive, rapid, and cost-effective approach, TcB measurement may function as an adjunctive tool for the initial clinical assessment and risk stratification of preeclamptic patients.